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1. Introduction
  Malaria is a public health problem of which about 300-
500 million people experience clinical episodes and 
1.4-2 million deaths occur annually[1]. Malaria is said 
to kill a child every 30 seconds, since with the onset of 
severe malaria, death may occur within 24 h or less[2]. In 
Nigeria, malaria accounts for 30%-50% morbidity and 25% 
mortality in infants[3,4]. During the past 30 years, malaria 
parasites especially Plasmodium falciparum (P. falciparum) 
have rapidly developed resistance to commonly used 
antimalarial drugs[4]. A dramatic recrudescence of malaria 
is ongoing due to this increasing resistance to parasites and 
the progressive resistance of the vectors to insecticides[5]. 
The greatest impact of the disease is on the poor people of 
the world and most of these populations are found in the 
rural settings especially in African communities where the 
people have poor nutritional status and also lack access to 
good health facilities. Thus, the rural dwellers depend more 
on herbs and other forms of traditional medicines for cure[4].
  Phyllanthus amarus  Schum and Thonn (family 
Euphorbiaceae) (P. amarus) is a perennial herb that has 
been widely used in Ayurvedic medicines for over 2 000 
years. It is a common weed, which grows well in moist, 
shady and sunny places and is widely distributed in almost 
all tropical countries and regions including America, 
India and Nigeria. It is commonly called ‘stonebreaker’, 
‘windbreaker’, ‘gulf leaf flower’ or ‘gala of wind’. The 
different plant parts are ethnobotanically used in various 
diseases and disorders[6]. For example the leaves are 
used as expectorant and diaphoretic, and the fruits as 
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carminative, laxative, astringent, diuretic, diaphoretic and 
tonic to the liver[7]. Research have shown that the plant 
has demonstrated anti- viral activity against hepatitis B 
virus[8,9], hepatoprotective[10,11], anti-carcinogenic[12,13], 
antimutagenics, anti-nociceptive and anti-inflammatory[14], 
antidiabetic and antilipidemic[15]activities. In some parts of 
Nigeria, the whole plant is washed and chewed for menstrual 
pain, stomach pain and tooth-ache[16]. The phytoconstituents 
present in P. amarus are alkaloids, flavanoids, hydrolysable 
tannins, polyphenols and lignans[10].
  Recent studies done on the efficacy of herbal remedies 
used by herbalist in Oyo state Nigeria for the treatment 
of malaria infection have shown that majority of the rural 
dwellers depend on herbal remedies and P. amarus was 
found to be one of the major components in the efficacious 
remedies[17]. In South eastern Nigeria, the roots are usually 
soaked in gin (alcoholic spirit distilled from grain or malt) 
and taken for the treatment of malaria[18]. Chukwujekwu 
et al[19] used the parasite lactate dehydrogenase test to 
demonstrate the in vitro activity of the petroleum ether 
extract of P. amarus against P. falciparum. The aqueous 
extract of the leaves and stem of P. amarus has been 
reported to possess a dose dependent schizonticidal activity 
on P. berghei when administered intraperitoneally to Swiss 
albino mice, in early and established infections[20]. However, 
no work has been done to assess the in vivo antiplasmodial 
activity of the extracts of the whole plant against P. yoelii 
a resistant malaria parasite used commonly used in animal 
studies. Thus, the aim of this study is to assess the in vivo 
antiplasmodial activity of the extracts and formulated capsules 
of P. amarus on Swiss Albino mice infected with P. yoelii.
2. Materials and methods
  The materials used were chloroquine phosphate obtained 
from Evans Plc (Lagos, Nigeria), artesunate/amodiaquine 
combination tablet (G-Sunate® kit) from Greenlife Pharma, 
(Lagos, Nigeria), pyrimethamine from S-KG Pharma (Lagos, 
Nigeria), ethanol, methanol, Giemsa stain and 3% Tween 
80  all obtained from Sigma Chemical Company (St Louis, 
USA). Swiss albino mice [weighing (20依2) g] of either 
sex were obtained from Biovaccines Ltd (former Federal 
Vaccine Production Laboratory) Lagos, Nigeria. The plant 
(Phyllanthus amarus) was purchased from Alasalatu herbal 
market in Mushin, Lagos-Nigeria and authenticated by 
Professor Dele Olowokudejo of the department of Botany 
and Microbiology, Faculty of Science, University of Lagos. 
A voucher specimen was deposited in the departmental 
herbarium. The parasite, non lethal strain of P. yoelii (17
伊) was obtained from the Nigerian Institute of Medical 
Research, Lagos, Nigeria and maintained in mice by weekly 
passage.
2.1. Preparation of plant extract
  The whole plant was washed and dried in an oven (Model 
BS 250, GallenKamp Co., UK) at a temperature of 50 曟 for 
48 h. The dried plant was powdered using a laboratory mill 
(Kenwood Ltd, Hertfordshire, UK). The aqueous and ethanol 
extracts were prepared by soaking 350 g of the powdered 
plant material with 1.3 L of distilled water and 1.5 L of 
ethanol respectively, using the soxhlet apparatus (Corning, 
USA).  The extract was concentrated at 50 曟 using a rotary 
evaporator (Corning, USA) and then evaporated to dryness in 
a vacuum dessicator. The dried extracts were stored in the 
refrigerator.
  The pH of 5% solution of the extract was determined using 
pH meter (Model 120, Thermorion) and the microbial limit 
was determined using established procedure.
2.2. Formulation of capsules
  The powder mix with a basic formula of dried aqueous 
extract (50% w/w) magnesium stearate (1% w/w), maize 
starch (5% w/w) and lactose (44% w/w) was dry mixed to 
obtain a homogeneous mixture and the moisture content 
determined with an Ohaus moisture balance (Ohaus Scale 
Corporation, USA) and found to be 1.7% w/w. The tapped 
and bulk densities of the powder-mix were determined 
using standard methods. Capsule [(400依5) mg] formulations 
were prepared by manually filling the hard gelatin capsule 
shells (Therapeutic Laboratories, Lagos, Nigeria). The 
mean weight and disintegration times of the capsules were 
determined using established methods.
2.3. Acute toxicity test
  Sixty-five Swiss albino mice [(20依2) g] were divided into 
thirteen groups of five mice per group, housed in standard 
cages in a well ventilated environment and allowed had 
free access to food and water. The animals were allowed to 
acclimatize for seven days before the commencement of the 
experiment. All animals were fasted for twelve hours before 
administration of the extracts. Six groups each received 
either the aqueous or ethanol extract orally using a stainless 
metallic feeding canula at a dose range of 400-1 600 mg/kg 
bw. The thirteenth group received 0.2 mL of distilled water 
to serve as control. The animals were keenly observed for 
two hours after the administration and then regularly for 48 
h.
2.4. Inoculation procedure
  Inoculation of mouse was done intra-peritonially (i.p.) 
with 0.2 mL of infected blood obtained from the eye orbit 
of the donor mouse which had 30.6% parasitaemia.  Thin 
blood films were made by collecting blood from the tail of 
the animals and stained with Giemsa stain after fixing with 
methanol. The percentage parasitaemia was determined by 
counting the number of parasitized red blood cells out of 
1 000 blood cells in ten randomly selected microscopic 
fields.  The mean percentage suppression of parasitaemia 
was calculated as:
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Suppression (%)  = 
parasitaemia in control (%) –parasitaemia in treated (%) 
parasitaemia in control (%)
伊100
    
2.5. Repository (chemoprophylactic) test
  The chemoprophylactic test was done using established 
methods[21,22]. Fifty Swiss albino mice [(20依2) g] were 
randomly assigned to ten groups of five each. Four groups each 
received either the aqueous or ethanol extracts, one group was 
given the standard drug (pyrimethamine 1.2 mg/kg/day) while 
the tenth group received 0.2 mL distilled water to serve 
as control.  The extracts were administered orally at daily 
doses ranging from 200-1 600 mg/kg/day for five consecutive 
days and then on the sixth day, the animals were inoculated 
intra-peritoneally (i.p.) with 0.2 mL of infected blood 
containing P. yoelii parasitized red blood cells from a 
donor mouse having 30.6% parasitaemia. Parasitaemia was 
monitored every two days after administering the infected 
blood till the sixth day to monitor the parasitaemia.
2.6. Schizontocidal (chemotherapeutic) test
  The schizontocidal (chemotherapeutic) effect of the extracts 
and formulated capsules were done using established 
methods[21,22]. Seventy Swiss albino mice [(20依2) g] randomly 
assigned to fourteen groups and infected with parasitized 
erythrocytes as earlier described and microscopy of the 
blood smear confirmed the establishment of the infection 
after five days.
  Four groups each received either the aqueous or ethanol 
extract orally at a dose ranging from 200-1 600 mg/kg/
day, three groups received the formulated capsules, one 
group each received chloroquine 5 mg/kg/day, artesunate/
amodiaquine 2 mg/kg/day and 0.2 mL of distilled water for 
five consecutive days. Parasitaemia was determined on the 
sixth day after commencing treatment.
2.7. Statistical analysis
  Data obtained were expressed as mean 依 SEM (standard 
error of the mean).  The student’s t-test was used to assess 
if there were any difference in the data obtained.  P values 
less than 0.05 were considered statistically significant.
3. Results
  The pH of 5% dispersion of the extract was 6.72 and 
the microbial test showed that there were no microbial 
contaminations in the extract. The acute toxicity tests 
revealed that there were no physical signs of toxicity or 
death recorded at all the doses employed. Thus, the plant 
extracts can be regarded as safe. The repository effect was 
determined after daily administration of the extract for five 
days before the inoculation of the mice with the parasite. 
The percentage of parasitaemia determined six days post 
inoculation of P. yoelii are presented in Table 1. The result 
showed that prophylactic administration of both aqueous and 
ethanol extracts of the plant caused a significant (P<0.001) 
delay in the onset of infection compared with control. The 
repository effects of P. amarus was dose-dependent with 
the aqueous extract showing higher chemosuppression 
compared to the ethanol extracts. However, the standard 
drug, pyrimethamine, given at a dose of 1.2 mg/kg body 
weight produced a higher (82.51%) chemo-suppression 
compared to the extracts (78.65% for aqueous extract 
and 78.53% for the ethanol extract) at the highest dose 
of 1 600 mg/kg bw. Statistical analysis showed that there 
were no statistically significant (P>0.05) difference in the 
chemosuppression effect of the extract especially at high 
doses and the standard drug.
  The results of the chemotherauptic activity of P. amarus 
extract on established P. yoelii infection are presented in 
Table 2. The results show that the extracts of P. amarus 
showed a dose-dependent chemotherapeutic effect with the 
aqueous extract showing better chemotherapeutic activity 
than the ethanol extract at corresponding doses although 
there were no statistically significant (P>0.05) difference in 
their effects.  The chemotherapeutic effect of the extracts 
were comparable to the standard chemotherapeutic drug 
used in chloroquine resistant Plasmodium infection, artesunate/
amodiaquine, especially at higher doses (1 600 mg/kg/day). The 
plot of the percentage of parasitaemia vs. time is presented 
in Figure 1. The graph shows that there was a reduction 
in the percent parasitaemia with time. The percentage of 
parasitaemia obtained for the extract at a dose of 200 mg/kg/
day bw was similar to those of chloroquine at a dose of 5 mg/
kg/day bw, while the percentage of parasitaemia obtained at 
high doses of 1 600 mg/kg/day bw was similar to the effects 
obtained for the artesunate/amodiaquine combination tablet 
at a dose of 2 mg/kg bw. This indicates that the extract 
would be useful in the treatment of different degree of 
malaria infection depending on the dose administered.
Artesunate/amodiaquine
0.002/0.006 g/kg
Ethanol extract
1 600 mg/kg
Ethanol extract
200 mg/kg
Aqueous extract
1 600 mg/kg
Aqueous extiact
200 mg/kg
Distilled water 0.2 mL
Chloroquine 5 mg/kg
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Figure 1. The effect of different doses of Phyllanthus amarus extracts 
on Plasmodium yoelii infection in mice.
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   The result of the material properties of the powder mix 
(extract and excipients) showed that the bulk density of the 
powder was 0.588 g/cm3. The capsules formulated with the 
aqueous extract of P. amarus had a mean weight of (399.6
依0.1) mg and an average disintegration time of 4.34 min. 
The results of the chemotherapeutic activity of the capsule 
formulation are presented in Table 3. The capsules showed 
a dose dependent chemotherapeutic activity similar to those 
of the aqueous extract. The plot of suppression vs. the dose 
of the aqueous extract present in the capsule formulation 
is presented in Figure 2. From the graph, the dose of 
extract in the capsule equivalent to those of the extract was 
extrapolated. The results showed that the percentage of 
suppression for the capsule formulation equivalent to 200 
mg/kg bw and 400 mg/kg bw of the extract was 55% and 64% 
respectively. This indicates that the capsule formulations 
showed better activity than when the extract was 
administered alone. Statistical analysis showed that there 
were no significant difference (P>0.05) in the antiplasmodial 
activity of both extract and capsule formulation. This 
indicates that the excipients included in the formulation did 
not affect the activity of the extract against the parasite.
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Figure 2. The plot of the percentage of suppression of Plasmodium 
yoelii infection in mice vs. doses of Phyllanthus amarus extracts 
present in the capsule formulation.
4. Discussion
  Plants have always been a good source of chemotherapeutic 
Table 1
Chemoprophylactic (repository) effects of Phyllanthus amarus extracts (mean依SEM, n=5).
Drug Dose (mg/kg/day) Parasitaemia (%) Suppression (%)
Aqueous extract    200.0 4.86依0.05 41.37
   400.0 3.85依0.02 53.56
   800.0 1.92依0.02 76.56
1 600.0 1.77依0.18 78.65
Ethanol extract    200.0 5.12依0.23 38.24
   400.0 4.16依0.16 49.82
   800.0 2.14依0.29 74.19
1 600.0 1.78依0.43 78.53
Pyrimethamine (Standard)        1.2 1.45依0.03 82.51
Distilled water (Control)        0.2 mL 8.29依0.02    -
Table 2
Chemotherapeutic (Schizontocidal) activity of the different doses of the extracts of Phyllanthus amarus during established infection (mean依SEM, 
n=5).
Drug description Dose (mg/kg) Parasitaemia (%) Suppression (%)
Aqueous extract    200 3.33依0.12 56.07
   400 2.36依0.20 68.02
   800 1.67依0.18 77.97
1 600 1.42依0.42 81.27
Ethanol extract    200 3.66依0.04 51.72
   400 2.43依0.12 67.94
   800 1.95依0.10 74.27
1 600 1.65依0.01 78.23
Chloroquine        5 2.69依0.05 52.37
Artesunate/amodiaquine        2/6 0.92依0.04 87.86
Distilled water (control)        0.2 mL 5.54依0.01   0.00
Table 3
Chemotherapeutic activity of the formulated capsules using aqueous extract of Phyllanthus amarus during established infection (mean依SEM, 
n=5).
Drug Dose (mg/kg) Parasitaemia (%) Suppression (%)
Capsule    400 3.89依0.03 48.68
   800 2.36依0.20 62.27
1 600 2.32依0.03 69.13
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agents. The first antimalarial drug was quinine, isolated 
from the bark of Cinchona species (Rubiaceae). Chloroquine 
is a first line drug in the treatment of malaria until recently, 
when it has become resistant to the malaria parasite, P. 
falciparum[1]. The aqueous extract demonstrated a slightly 
higher antiplasmodial (chemotherapeutic and prophylactic) 
activity than the ethanol extract at all doses administered. 
Statistical analysis showed that there were no significant 
difference in the percent reduction of parasitaemia of the two 
extracts. The antiplasmodial activity of the extracts against 
the resistant strains of the parasite was dose-dependent. 
This is similar to the results obtained for the aqueous extract 
of the stem and leaves of P. amarus against the chloroquine 
sensitive strains of P. berghei[20].
  The repository effect of the extract was dose dependent 
delay in the onset of Plasmodium infection in the animals. 
There were significant (P<0.05) differences in the repository 
activity of the extracts and the standard drug, pyrimethamine 
except at high doses where the repository effects were 
comparable. This indicates that high doses of aqueous and 
ethanol extract of P. amarus could be used as a substitute 
for the standard drug in the prevention of malaria infection. 
The schizonticidal activity of the extract in established 
infection was also dose dependent. Chloroquine which is the 
standard drug for the treatment of malaria infection showed 
52.3% suppression which is similar to the activity of the 
extracts at low doses (200 mg/kg/day). On the other hand, 
the schizonticidal activity of the extract at high doses (1 600 
mg/kg/day) was similar to those of artesunate/amodiaquine. 
The results also showed that there was significant (P<0.05) 
difference in the chemotherapeutic effects of chloroquine 
and artesunate/amodiaquine tablets, indicating that the 
artesunate/amodiaquine combination are more effective in 
the treatment of resistant strains of Plasmodium.
  The results showed that capsule formulation equivalent 
to the dose administered for the extract showed percent 
suppression equivalent to those obtained when the extract 
was administered alone. There were no significant (P>0.05) 
difference in the antiplasmodial activity of both extract 
and capsule formulation. This indicates that the excipients 
included in the formulation did not affect the activity of the 
extract against the parasite.
  The results obtained indicate that the extracts of the whole 
plant of P. amarus possess repository and chemotherapeutic 
effects against resistant strains of P. yoelii in Swiss albino 
mice.
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